Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167598647> ?p ?o ?g. }
- W2167598647 abstract "OBJECTIVE:The Guanacaste study (Guanacaste Project, or GP), was designed to investigate the role of human papillomavirus (HPV) infection and its cofactors in the development of cervical neoplasia and to evaluate new cervical cancer screening technologies. The follow-up phase of the GP was designed to study why a small proportion of women infected with HPV develop cervical intraepithelial neoplasia grade 2 (CIN 2), CIN 3, or cancer (these three together are globally referred to as > CIN 2, that is, CIN 2 or worse). The purpose of this article is to describe this prospective study in detail and to present the preliminary findings regarding the incidence of cervical neoplasia. METHODS: A cohort of 10 049 randomly selected women from 18 to 97 years old from Guanacaste, a province in northwestern Costa Rica, was intensively screened in 1993-1994 and then followed up for seven years after being enrolled. A questionnaire for demographic and risk factors was administered, and a pelvic examination was performed on sexually active women at each follow-up visit in order to obtain samples for screening tests and for research purposes. The final diagnosis given at the end of the enrollment phase categorized women into several groups according to the perceived risk of their developing either high-grade precursors of cancer or cancer. These groups were followed up at different intervals according to the risk of developing > CIN 2. The most active follow-up (every 6-12 months) was concentrated on the women most likely to develop > CIN 2, based on cytology (n= 492). The remainder of the cohort was followed either annually (n= 2 574) or after five to seven years of passive follow-up (n= 3 926). All women with possibly severe lesions detected by any technique were referred to colposcopy for further evaluation and treatment, and they were also censored from the study. Lesions >CIN 2 served as both the censoring outcome and our surrogate for cancer risk. RESULTS: Participation during follow-up was high (near 90%). Suspected > CIN 2 by any screening technique censored 4.6% of women. Most of the women censored because of suspected > CIN 2 came from the large group perceived at entry as being at low risk of developing > CIN 2, but the greatest rates of progression to > CIN 2 were observed among women perceived at entry to be at highest risk of >CIN 2, based on their cytology, virology, or sexual behavior. CONCLUSIONS: The GP is the largest population-based longitudinal cohort for the study of HPV and cervical neoplasia in the world, and its results will hopefully let us soon plan future worldwide prevention strategies. Research projects such as this one require the long-term commitment of a large multidisciplinary team and ample financial resources. The intensive effort and expertise applied in all aspects of this study were key factors in its success as a model of cooperative, interdisciplinary cancer research in Latin America. Quality control played an important role at all times during the study and made it possible to adapt new diagnostic and screening technology to Guanacaste. The systematic follow-up of a population-based group of close to 10 000 women in Guanacaste should permit careful, time-dependent evaluation of factors postulated to be linked to the development of cervical cancer as well as the evaluation of clinical markers of disease progression. The study results that have already been published have validated sensitive screening techniques and have also promoted the use of more affordable screening techniques in resource-poor, developing countries. The GP has also contributed to building knowledge for the search for vaccines against HPV as part of the effort to develop an effective tool to reduce the incidence and mortality of cervical cancer worldwide." @default.
- W2167598647 created "2016-06-24" @default.
- W2167598647 creator A5009475462 @default.
- W2167598647 creator A5011328997 @default.
- W2167598647 creator A5021442543 @default.
- W2167598647 creator A5024227482 @default.
- W2167598647 creator A5025470510 @default.
- W2167598647 creator A5037112979 @default.
- W2167598647 creator A5040784388 @default.
- W2167598647 creator A5053917890 @default.
- W2167598647 creator A5056303296 @default.
- W2167598647 creator A5058686377 @default.
- W2167598647 creator A5059243875 @default.
- W2167598647 creator A5059951020 @default.
- W2167598647 creator A5064828880 @default.
- W2167598647 creator A5065827206 @default.
- W2167598647 creator A5067178086 @default.
- W2167598647 creator A5068122935 @default.
- W2167598647 creator A5072430357 @default.
- W2167598647 creator A5087263703 @default.
- W2167598647 creator A5087709385 @default.
- W2167598647 date "2004-02-01" @default.
- W2167598647 modified "2023-10-16" @default.
- W2167598647 title "Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10 000 women in Guanacaste, Costa Rica" @default.
- W2167598647 cites W1562193383 @default.
- W2167598647 cites W1947425084 @default.
- W2167598647 cites W1968904767 @default.
- W2167598647 cites W1977942351 @default.
- W2167598647 cites W1985439427 @default.
- W2167598647 cites W1989120566 @default.
- W2167598647 cites W2026599341 @default.
- W2167598647 cites W2031908863 @default.
- W2167598647 cites W2035680424 @default.
- W2167598647 cites W2035833603 @default.
- W2167598647 cites W2040204181 @default.
- W2167598647 cites W2044453012 @default.
- W2167598647 cites W2072158802 @default.
- W2167598647 cites W2075964966 @default.
- W2167598647 cites W2092655019 @default.
- W2167598647 cites W2101809078 @default.
- W2167598647 cites W2113839478 @default.
- W2167598647 cites W2115190531 @default.
- W2167598647 cites W2117771134 @default.
- W2167598647 cites W2138380445 @default.
- W2167598647 cites W2142068436 @default.
- W2167598647 cites W2143391725 @default.
- W2167598647 cites W2150250521 @default.
- W2167598647 cites W2164188216 @default.
- W2167598647 cites W2169918603 @default.
- W2167598647 cites W2171749878 @default.
- W2167598647 cites W2186029696 @default.
- W2167598647 cites W2413328609 @default.
- W2167598647 cites W2528985464 @default.
- W2167598647 doi "https://doi.org/10.1590/s1020-49892004000200002" @default.
- W2167598647 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15030652" @default.
- W2167598647 hasPublicationYear "2004" @default.
- W2167598647 type Work @default.
- W2167598647 sameAs 2167598647 @default.
- W2167598647 citedByCount "71" @default.
- W2167598647 countsByYear W21675986472012 @default.
- W2167598647 countsByYear W21675986472013 @default.
- W2167598647 countsByYear W21675986472014 @default.
- W2167598647 countsByYear W21675986472015 @default.
- W2167598647 countsByYear W21675986472017 @default.
- W2167598647 countsByYear W21675986472018 @default.
- W2167598647 countsByYear W21675986472019 @default.
- W2167598647 countsByYear W21675986472020 @default.
- W2167598647 countsByYear W21675986472021 @default.
- W2167598647 countsByYear W21675986472022 @default.
- W2167598647 countsByYear W21675986472023 @default.
- W2167598647 crossrefType "journal-article" @default.
- W2167598647 hasAuthorship W2167598647A5009475462 @default.
- W2167598647 hasAuthorship W2167598647A5011328997 @default.
- W2167598647 hasAuthorship W2167598647A5021442543 @default.
- W2167598647 hasAuthorship W2167598647A5024227482 @default.
- W2167598647 hasAuthorship W2167598647A5025470510 @default.
- W2167598647 hasAuthorship W2167598647A5037112979 @default.
- W2167598647 hasAuthorship W2167598647A5040784388 @default.
- W2167598647 hasAuthorship W2167598647A5053917890 @default.
- W2167598647 hasAuthorship W2167598647A5056303296 @default.
- W2167598647 hasAuthorship W2167598647A5058686377 @default.
- W2167598647 hasAuthorship W2167598647A5059243875 @default.
- W2167598647 hasAuthorship W2167598647A5059951020 @default.
- W2167598647 hasAuthorship W2167598647A5064828880 @default.
- W2167598647 hasAuthorship W2167598647A5065827206 @default.
- W2167598647 hasAuthorship W2167598647A5067178086 @default.
- W2167598647 hasAuthorship W2167598647A5068122935 @default.
- W2167598647 hasAuthorship W2167598647A5072430357 @default.
- W2167598647 hasAuthorship W2167598647A5087263703 @default.
- W2167598647 hasAuthorship W2167598647A5087709385 @default.
- W2167598647 hasBestOaLocation W21675986471 @default.
- W2167598647 hasConcept C120665830 @default.
- W2167598647 hasConcept C121332964 @default.
- W2167598647 hasConcept C121608353 @default.
- W2167598647 hasConcept C126322002 @default.
- W2167598647 hasConcept C131872663 @default.
- W2167598647 hasConcept C142724271 @default.
- W2167598647 hasConcept C18823058 @default.
- W2167598647 hasConcept C188816634 @default.
- W2167598647 hasConcept C2777343196 @default.